Azithromycin reduces COPD exacerbation in a study

08/24/2011 | HealthDay News

A study of 1,142 people with advanced chronic obstructive pulmonary disease found that those who were given 250 milligrams of antibiotic azithromycin daily for one year had a 27% reduced risk of flare-ups compared with those who received placebo. Researchers noted in The New England Journal of Medicine that those who took the antibiotic also reported improvements in their quality of life.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA